139 related articles for article (PubMed ID: 16023754)
21. Effect of additives on the release of a model protein from PLGA microspheres.
Kang F; Singh J
AAPS PharmSciTech; 2001 Dec; 2(4):30. PubMed ID: 14727867
[TBL] [Abstract][Full Text] [Related]
22. Effect of gamma-sterilization process on PLGA microspheres loaded with insulin-like growth factor-I (IGF-I).
Carrascosa C; Espejo L; Torrado S; Torrado JJ
J Biomater Appl; 2003 Oct; 18(2):95-108. PubMed ID: 14621336
[TBL] [Abstract][Full Text] [Related]
23. Pluronic F127 gel effectively controls the burst release of drug from PLGA microspheres.
Wang Y; Gao JQ; Chen HL; Zheng CH; Liang WQ
Pharmazie; 2006 Apr; 61(4):367-8. PubMed ID: 16649559
[TBL] [Abstract][Full Text] [Related]
24. Effects of process and formulation parameters on characteristics and internal morphology of poly(d,l-lactide-co-glycolide) microspheres formed by the solvent evaporation method.
Mao S; Shi Y; Li L; Xu J; Schaper A; Kissel T
Eur J Pharm Biopharm; 2008 Feb; 68(2):214-23. PubMed ID: 17651954
[TBL] [Abstract][Full Text] [Related]
25. Hydrolytic degradation characteristics of irradiated multi-layered PLGA films.
Joachim Loo SC; Jason Tan WL; Khoa SM; Chia NK; Venkatraman S; Boey F
Int J Pharm; 2008 Aug; 360(1-2):228-30. PubMed ID: 18514448
[TBL] [Abstract][Full Text] [Related]
26. Versatility of biodegradable poly(D,L-lactic-co-glycolic acid) microspheres for plasmid DNA delivery.
Díez S; Tros de Ilarduya C
Eur J Pharm Biopharm; 2006 Jun; 63(2):188-97. PubMed ID: 16697172
[TBL] [Abstract][Full Text] [Related]
27. Effect of the molecular weight of poly(ethylene glycol) used as emulsifier on alpha-chymotrypsin stability upon encapsulation in PLGA microspheres.
Castellanos IJ; Flores G; Griebenow K
J Pharm Pharmacol; 2005 Oct; 57(10):1261-69. PubMed ID: 16259754
[TBL] [Abstract][Full Text] [Related]
28. Polymeric nanoparticles encapsulating betamethasone phosphate with different release profiles and stealthiness.
Ishihara T; Kubota T; Choi T; Takahashi M; Ayano E; Kanazawa H; Higaki M
Int J Pharm; 2009 Jun; 375(1-2):148-54. PubMed ID: 19481700
[TBL] [Abstract][Full Text] [Related]
29. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres.
He JT; Su HB; Li GP; Tao XM; Mo W; Song HY
Int J Pharm; 2006 Feb; 309(1-2):101-8. PubMed ID: 16413979
[TBL] [Abstract][Full Text] [Related]
30. Gamma irradiation effects on poly(DL-lactictide-co-glycolide) microspheres.
Montanari L; Costantini M; Signoretti EC; Valvo L; Santucci M; Bartolomei M; Fattibene P; Onori S; Faucitano A; Conti B; Genta I
J Control Release; 1998 Dec; 56(1-3):219-29. PubMed ID: 9801445
[TBL] [Abstract][Full Text] [Related]
31. Effects of lung surfactants on rifampicin release rate from monodisperse rifampicin-loaded PLGA microspheres.
Tomoda K; Makino K
Colloids Surf B Biointerfaces; 2007 Mar; 55(1):115-24. PubMed ID: 17197161
[TBL] [Abstract][Full Text] [Related]
32. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
33. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
34. NMR and confocal microscopy studies of the mechanisms of burst drug release from PLGA microspheres.
Messaritaki A; Black SJ; van der Walle CF; Rigby SP
J Control Release; 2005 Nov; 108(2-3):271-81. PubMed ID: 16169112
[TBL] [Abstract][Full Text] [Related]
35. Impact of PEG and PEG-b-PAGE modified PLGA on nanoparticle formation, protein loading and release.
Rietscher R; Czaplewska JA; Majdanski TC; Gottschaldt M; Schubert US; Schneider M; Lehr CM
Int J Pharm; 2016 Mar; 500(1-2):187-95. PubMed ID: 26784983
[TBL] [Abstract][Full Text] [Related]
36. Biodegradable heparin-loaded microspheres: carrier molecular composition and microsphere structure.
Luo X; Qiu D; He B; Wang L; Luo J
Macromol Biosci; 2006 May; 6(5):373-81. PubMed ID: 16685689
[TBL] [Abstract][Full Text] [Related]
37. How cyclodextrin incorporation affects the properties of protein-loaded PLGA-based microspheres: the case of insulin/hydroxypropyl-beta-cyclodextrin system.
De Rosa G; Larobina D; Immacolata La Rotonda M; Musto P; Quaglia F; Ungaro F
J Control Release; 2005 Jan; 102(1):71-83. PubMed ID: 15653135
[TBL] [Abstract][Full Text] [Related]
38. Effects of gamma-irradiation on PLGA microspheres loaded with thienorphine.
Yang Y; Gao Y; Mei X
Pharmazie; 2011 Sep; 66(9):694-7. PubMed ID: 22026126
[TBL] [Abstract][Full Text] [Related]
39. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
He JT; Tao XM; Mo W; Song HY
Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
[TBL] [Abstract][Full Text] [Related]
40. Effects of pulmonary surfactant system on rifampicin release from rifampicin-loaded PLGA microspheres.
Tomoda K; Kojima S; Kajimoto M; Watanabe D; Nakajima T; Makino K
Colloids Surf B Biointerfaces; 2005 Sep; 45(1):1-6. PubMed ID: 16099143
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
